A phase II, multicenter study of encorafenib/binimetinib followed by a rational triple-combination after progression in patients with advanced BRAF V600-mutated melanoma (LOGIC2) Meeting Abstract
| Authors: | Dummer, R.; Sandhu, S. K.; Miller, W. H.; Butler, M. O.; Blank, C. U.; Muñoz-Couselo, E.; Burris, H. A. 3rd; Postow, M. A.; Chmielowski, B.; Middleton, M. R.; Berking, C.; Hassel, J. C.; Gesierich, A.; Mauch, C.; Kleha, J.; Gollerkeri, A.; Harney, A.; Pickard, M. D.; Ascierto, P. A. |
| Abstract Title: | A phase II, multicenter study of encorafenib/binimetinib followed by a rational triple-combination after progression in patients with advanced BRAF V600-mutated melanoma (LOGIC2) |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Start Page: | 508s |
| Language: | English |
| ACCESSION: | WOS:000560368300128 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.10022 |
| Notes: | Meeting Abstract: 10022 -- Source: Wos |
